Navigation Links
LCS Constructors, Inc. Completes First Major Phase of Abraxis BioScience Project
Date:4/29/2010

IRVINE, Calif., April 29 /PRNewswire/ -- Abraxis BioScience initially engaged LCS Constructors, Inc. to perform an evaluation of the former ICN/Valient Pharmaceutical building in Costa Mesa, California prior to their purchasing this 165,000 square foot building. The "due diligence report" revealed an array of issues that required repair or retro-fit prior to occupying the building, and once the building purchase was complete, Abraxis called upon LCS to serve as Design-Builder for a multi-phase renovation.

With Senior Project Manager David P. Carlos leading the way and Superintendent Jim Koons heading up daily production, LCS recently completed significant seismic upgrades as well as restoring and renovating existing laboratory space to Abraxis' specifications. LCS was charged with ensuring that the end result would be a new "state-of-the-art" laboratory which includes labs for chemistry, biology, formulation, and a Biological Safety Lab 3 (BSL3).

The biggest challenges throughout the project were, literally, the seismic upgrades. Working on the second floor, the size and weight alone of the dampeners was too much to just place them anywhere. With each dampener between 15' and 19' long and weighing between 700 lbs and 1000 lbs each, they were just too large to install without significant planning.

The team strategized to figure out the best location for the dampeners which was both close to the work but out of the way, keeping both production and safety in mind. Because the seismic dampeners were not standard equipment, the installation presented other unique challenges in terms of tolerances. Additionally, in order to accurately plan for the installation of the dampeners, seismic models were created. These seismic models were a key element for understanding the purpose and the workings for this project.

"This has been a fantastic client and job to work on," stated Koons. And, although the team faced several unique challenges that accompanied these seismic upgrades, they were resourceful and that, combined with patience, planning and strategy, led to the successful completion of the first major phase of this project.

The relocation of Abraxis' research and development group from Marina Del Rey to Costa Mesa will provide the company more space to grow their operations. LCS was proud to renovate the new facility which will provide the technology necessary to propel Abraxis closer to their goals of finding new treatments for cancer and other pathological disorders.


'/>"/>
SOURCE LCS Constructors, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... The American Pharmacists Association (APhA) is excited ... Medically Underserved Areas Enhancement Act (H.R. 592) ... was previously introduced in the 114 th session ... through pharmacists and their patient care services. ... (R-KY), G.K. Butterfield (D-NC), Tom ...
(Date:1/23/2017)... ALBANY, New York , January 23, 2017 ... Non-Invasive Prenatal Testing Market was valued at US$0.53 bn ... by expanding at a strong 17.50% CAGR between 2014 and 2022. ... - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... ...
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
Breaking Medicine Technology:
(Date:1/22/2017)... ... , ... "Photo Cloud allows FCPX users to add favorited photos to any ... said Christina Austin - CEO of Pixel Film Studios. , To begin, select ... Presets include scenes with one, three, four or five focus points. There are five ...
(Date:1/21/2017)... ... ... Caronlab Australia, an Australian company known for health and beauty products such ... where it benefited from outstanding meetings with major retail buyers. , Caron Labs has ... this trade show, the company had the chance to demonstrate its products and provide ...
(Date:1/21/2017)... ... ... perfect set of tools for video editors that want to create the illusion of rack ... of Pixel Film Studios. , Video editors using ProDOF can add realistic depth of ... from one area into the next. ProDOF comes with 0.5 second, 1.0 second, 1.5 ...
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you to ... the rest of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of ... Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower gel ...
(Date:1/21/2017)... Rosa, CA (PRWEB) , ... January 21, 2017 ... ... announce that Redwood Family Dermatology has recently joined their multi-specialty medical ... a full range of cosmetic services. , “We’re excited to add this excellent ...
Breaking Medicine News(10 mins):